Primary clinical endpoint
Primary efficacy endpoint is the motor performance after the intervention, as assessed by the Fugl‐Meyer assessment of the upper extremity (FMA‐UE). The upper‐extremity (UE) portion of the Fugl‐Meyer assessment (FMA‐UE, range 0‐66, 0 = no motor function, 66 = normal motor function) is the most frequently used scale to quantify post‐stroke motor recovery of the upper extremity [